Report Buyer, the online destination for business intelligence for major industry sector, has now added a new report on the cancer therapeutics market. “Cancer Therapeutics: The Worldwide Market” forecasts that the cancer therapeutics market will grow from around $46 billion in 2006 to more than $89 billion by 2011.
The potential for improved disease outcomes is vast and targeted cancer therapeutics are a very exciting prospect, offering the opportunity to improve patient survival from serious illnesses. With the market expecting more than $11 billion new therapeutics to gain approval within the next four years a global market of $89 billion may be a modest projection.
Innovation has been and remains the key to growth with the largest number of therapy approvals recorded in the US in 2006 and a further 50 therapies in Phase III or awaiting approval.
This study examines the global market for therapies for a broad range of cancers including: bladder, breast, cervical, colorectal, kidney, leukemia, liver, lung, lymphoma, melanoma, multiple myeloma, ovarian, and prostate among others. Therapy types covered in the report include chemotherapy, hormone and radiation therapy, immunotherapy and biotherapy, and adjunctive therapies.
It also includes extensive coverage of research and development pipelines, in-depth company profiles, four-region geographic breakdowns, over 160 tables and figures and more.
Report Buyer product ID: KAL00007
About Report Buyer
Report Buyer is a UK-based independent online store supplying business information on major industry sectors. These include the Automotive Industry, Banking & Finance, Energy & Utilities, Food & Drink, Telecoms and Pharma & Healthcare. The website now carries over 11,000 business information products, including market reports, studies and books. Report Buyer is the intelligent way to buy market research making it an essential resource for executives and information buyers worldwide. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest.